SEC filing record
Primary Source · SEC.gov

CraniUS LLC

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2026-03-06Last filing 2026-03-06

Raised

$19M

Investors

49

Min Invest

$50,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

CraniUS LLC is a Maryland limited liability company that first filed a Form D on August 20, 2021 and most recently amended it on March 6, 2026 in the Biotechnology industry group. The offering claims Rule 506(b) and covers equity. CraniUS LLC reported $19,000,000 sold from 49 investors of a $20,000,000 total offering as of the Form D filed March 6, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 12320 Cleghorn Rd, Cockeysville, MD 21030.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001878219
Entity NameCraniUS LLC
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeLimited Liability Company
Jurisdiction of OrganizationMaryland
Issuer Address12320 Cleghorn Rd, Cockeysville, MD 21030
Phone(410) 404-9151
Industry / Fund TypeBiotechnology
Securities TypeEquity
First Sale DateFebruary 13, 2026
Filing DateMarch 6, 2026
Accession Number0000950138-26-000005
Total Offering Amount$20,000,000
Total Amount Sold$19,000,000
Amount Remaining$1,000,000
Total Investors49
Non-Accredited InvestorsNone
Minimum Investment$50,000
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeNo Revenues
State (Issuer Address)MD
Amendment Count5 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

1

latest Mar 6, 2026

Critical / warning

0 / 0

0 watch · 1 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

2

raising, lapsed

Latest event New filer · Mar 6, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 filing event with values and deltas, latest 2026-03-06, and alerts on the next one
  • 2 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2026-03-06: 2 related persons added and 2 removed against the filing of 2022-05-25; 9 now listed. The names are in the Terminal feed.

Chad Gordon

Director · Baltimore, MD

Sharon Wolfington

Director · Baltimore, MD

Steven Klasko

Director · Baltimore, MD

Brian Moran

Director · Baltimore, MD

Elliot Stone

Director · Baltimore, MD

Joshua Scheinker

Director · Baltimore, MD

Brett Friedman

Director · Baltimore, MD

Oray Boston, Jr.

Director · Baltimore, MD

Michael Maglin

Executive Officer · Baltimore, MD

Questions About CraniUS LLC

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is CraniUS LLC?

CraniUS LLC is a Maryland limited liability company that filed a Form D with the SEC on March 6, 2026 in the Biotechnology industry group. The filing claims Rule 506(b) for an offering of equity.

Is CraniUS LLC legit?

AltStreet does not rate legitimacy; it reports the public record. CraniUS LLC filed a Form D with the SEC on March 6, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $19,000,000 sold to 49 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is CraniUS LLC registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that CraniUS LLC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has CraniUS LLC raised?

CraniUS LLC reported $19,000,000 sold from 49 investors of a $20,000,000 total offering as of the Form D filed March 6, 2026.

Who can invest in CraniUS LLC?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000.

What is the minimum investment in CraniUS LLC?

The Form D lists $50,000 as the minimum investment accepted from any outside investor as of March 6, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling CraniUS LLC and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind CraniUS LLC?

The Form D lists 9 related persons: Chad Gordon, director; Sharon Wolfington, director; Steven Klasko, director; Brian Moran, director; Elliot Stone, director; Joshua Scheinker, director; Brett Friedman, director; Oray Boston, Jr., director, and 1 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is CraniUS LLC located?

The issuer's address on its SEC filings is 12320 Cleghorn Rd, Cockeysville, MD 21030. Its phone number of record is 410-404-9151. It is organized under the laws of Maryland.

How long is the CraniUS LLC offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 3 amendments are on record for this CIK.

What is CraniUS LLC's revenue?

The Form D reports a revenue range of No Revenues.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.